Skip to content

Icodextrin vs. Glucose 2.5% on survival of patients on Peritoneal Dialysis

Icodextrin vs. Glucose 2.5% on technique survival of patients undergoing Automated Peritoneal Dialysis of unplanned start: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-97z4wh6
Enrollment
Unknown
Registered
2021-08-30
Start date
2021-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellittus

Interventions

Fifty adult patients that initiated unplanned Peritoneal Dialysis on treatment with Automated PD for at least 90 days and with a recent peritoneal equilibration test (PET) showing a D/P creatinine of
peritoneal dialysis

Sponsors

daniela ponce
Lead Sponsor
Botucatu School of Medicine
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult patients that initiated unplanned PD on treatment with APD for at least 90 days and with a recent peritoneal equilibration test (PET) showing a Dialysate/Plasma creatinine of higher than 0.50; low-average; highaverage or high transporter have been included in the study.

Exclusion criteria

Exclusion criteria: Exclusion criteria include life expectancy of lower than1 year at baseline, positive sorology for human imunodeficiency virus (HIV); a peritonitis episode preceding the randomization by 1 month; any hospitalization due to cardiovascular, metabolic or infectious disease in the month preceding randomization; any known active cancer; pregnancy; and known allergy to icodextrin 7.5%

Design outcomes

Primary

MeasureTime frame
The primary outcome will be to assess the failure of the technique, that is, peritoneal dialysis. It is expected that the failure of the technique is greater in the control group. Failure of the technique will be defined as the change of dialysis method from peritoneal to hemodialysis.

Secondary

MeasureTime frame
Secondary outcomes will be to assess the volume control of both groups. It is expected that blood volume control is worse in the control group. The volume control will be determined through pressure control, weight and total body water measured by bioimpedance.

Countries

Brazil

Contacts

Public ContactDaniela Ponce
daniela.ponce@unesp.br+55-014-997625806

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 6, 2026